We report a case of a 66-year-old Caucasian female with a diagnosis of idiopathic orbital inflammatory disease (OID) refractory to azathioprine therapy. The coexistence of diabetes mellitus represented a relative contraindication to chronic prednisone use. After two infusions of rituximab, a chimeric anti-CD20+ antibody, ophthalmic signs and symptoms remarkably improved. To our knowledge, this is the first case of idiopathic OID successfully treated with rituximab.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10067-008-1040-8 | DOI Listing |
Publication Analysis
Top Keywords
idiopathic orbital
8
orbital inflammatory
8
inflammatory disease
8
treated rituximab
8
disease treated
4
rituximab report
4
report case
4
case 66-year-old
4
66-year-old caucasian
4
caucasian female
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!